These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11007709)

  • 21. Personal characteristics and outcomes of individuals with developmental disabilities who need support for self-injurious behaviour.
    Bradley V; Hiersteiner D; Rotholz D; Maloney J; Li H; Bonardi A; Bershadsky J
    J Intellect Disabil Res; 2018 Dec; 62(12):1043-1057. PubMed ID: 30022570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
    Schmahl C; Bohus M
    Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
    [No Abstract]   [Full Text] [Related]  

  • 23. Using analog baselines to assess the effects of naltrexone on self-injurious behavior.
    Garcia D; Smith RG
    Res Dev Disabil; 1999; 20(1):1-21. PubMed ID: 9987807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of naltrexone for treating pathologic skin picking behavior in an adolescent with Prader-Willi syndrome.
    Banga A; Connor DF
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):396-8. PubMed ID: 23083028
    [No Abstract]   [Full Text] [Related]  

  • 25. Refractory Self-Injurious Behavior in Severe Intellectual Disability Responsive to Topiramate: A Case Report.
    Hamm B; Khokhar N; Jimenez XF
    Psychosomatics; 2017; 58(2):209-212. PubMed ID: 28189287
    [No Abstract]   [Full Text] [Related]  

  • 26. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
    Bolm T; Piegler T
    Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preliminary study of altered skin temperature at body sites associated with self-injurious behavior in adults who have developmental disabilities.
    Symons FJ; Sutton KA; Bodfish JW
    Am J Ment Retard; 2001 Jul; 106(4):336-43. PubMed ID: 11414874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.
    Willemsen-Swinkels SH; Buitelaar JK; Nijhof GJ; van England H
    Arch Gen Psychiatry; 1995 Sep; 52(9):766-73. PubMed ID: 7654128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-injury in people with intellectual disability and epilepsy: a matched controlled study.
    Buono S; Scannella F; Palmigiano MB; Elia M; Kerr M; Di Nuovo S
    Seizure; 2012 Apr; 21(3):160-4. PubMed ID: 22244737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review.
    Ward F; Tharian P; Roy M; Deb S; Unwin GL
    Res Dev Disabil; 2013 Dec; 34(12):4293-303. PubMed ID: 24171827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with levetiracetam in a patient with pervasive developmental disorders, severe intellectual disability, self-injurious behavior, and seizures: a case report.
    Deriaz N; Willi JP; Orihuela-Flores M; Galli Carminati G; Ratib O
    Neurocase; 2012; 18(5):386-91. PubMed ID: 22059937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-injury among a community cohort of young children at risk for intellectual and developmental disabilities.
    MaClean WE; Tervo RC; Hoch J; Tervo M; Symons FJ
    J Pediatr; 2010 Dec; 157(6):979-83. PubMed ID: 20630541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naltrexone treatment of self-injurious thoughts and behaviors.
    Sonne S; Rubey R; Brady K; Malcolm R; Morris T
    J Nerv Ment Dis; 1996 Mar; 184(3):192-5. PubMed ID: 8600226
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationship between food refusal and self-injurious behavior: a case study.
    Kerwin ML; Ahearn WH; Eicher PS; Swearingin W
    J Behav Ther Exp Psychiatry; 1998 Mar; 29(1):67-77. PubMed ID: 9627826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior.
    Sandman CA; Touchette PE; Marion SD; Chicz-DeMet A
    Dev Psychobiol; 2008 Nov; 50(7):680-9. PubMed ID: 18688808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects of naltrexone on autistic behavior.
    Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
    Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of self-injurious behaviour by differential reinforcement and physical restraint.
    Jena SP
    Int J Rehabil Res; 1999 Sep; 22(3):243-7. PubMed ID: 10839680
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic effects and long-term efficacy of antidepressant medication for persons with developmental disabilities. Behavioral assessment in two cases of treatment-resistant aggression and self-injury.
    Luiselli JK; Blew P; Thibadeau S
    Behav Modif; 2001 Jan; 25(1):62-78. PubMed ID: 11151486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia.
    DeLucia B
    J Clin Psychopharmacol; 2017 Dec; 37(6):743-745. PubMed ID: 28891834
    [No Abstract]   [Full Text] [Related]  

  • 40. Adult head-banging and stereotypic movement disorders.
    Mendez MF; Mirea A
    Mov Disord; 1998 Sep; 13(5):825-8. PubMed ID: 9756153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.